Pharmaceuticals

Anti-Hypertensive Drugs Industry Forecast to Hit $40.74 Billion by 2029 With a Strong 1.7% CAGR

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Anti-Hypertensive Drugs Market?

The anti-hypertensive drugs market size has experienced a modest increase in recent years. It is anticipated to expand from $37.42 billion in 2024 to $38.03 billion in 2025, achieving a compound annual growth rate (CAGR) of 1.6%. This historical growth can be attributed to environmental and lifestyle influences, historical market competition, historical treatment preferences, economic conditions, and historical global health trends.

The anti-hypertensive drugs market size is projected to experience modest expansion over the coming years. This market is anticipated to reach $40.74 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 1.7%. Several factors are expected to drive this growth during the forecast period, including cost-effectiveness and affordability, emerging therapeutic innovations, epidemiological trends, regulatory changes and approvals, aging population dynamics, and healthcare policies and reimbursement changes. Key trends anticipated during this period encompass therapeutic innovation, epidemiological shifts, the regulatory landscape, healthcare policies, and advancements in diagnosis and monitoring.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2410&type=smp

What Are The Key Drivers Of Growth In The Anti-Hypertensive Drugs Market?

A largely inactive lifestyle is a significant impetus behind the expansion of the anti-hypertensive drug market. Additional factors contributing to rising hypertension rates include the intake of unhealthy food, insufficient healthy and balanced dietary practices, and inadequate rest resulting from inconsistent work schedules. This condition underlies at least 45% of fatalities from heart disease and 51% of fatalities from stroke. Upon receiving a hypertension diagnosis, individuals must utilize medication to manage the condition, with dosages adjusted according to its severity. As an illustration, data from May 2023, provided by the National Health Service, an England-based governmental body, indicates that the overall incidence of hypertension escalates with age, beginning at 9% for adults between 16 to 44 years old and climbing to 60% for individuals 65 and older. This dynamic fosters a consistent need for the product and serves as a key catalyst for the market’s expansion.

What Are The Major Segment Types Covered In The Anti-Hypertensive Drugs Market?

The anti-hypertensive drugs market covered in this report is segmented –

1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators

2) By Disease Source: Primary Hypertension, Secondary Hypertension

3) By End Users: Hospitals, Clinics, Homecare

Subsegments:

1) By Diuretics: Thiazide Diuretics, Loop Diuretics, Potassium-Sparing Diuretics

2) By Angiotensin Receptor Blockers (ARBs): Losartan, Valsartan, Irbesartan, Candesartan

3) By Angiotensin Converting Enzyme (ACE) Inhibitors: Enalapril, Lisinopril, Ramipril, Benazepril

4) By Beta Blockers: Metoprolol, Atenolol, Carvedilol, Bisoprolol

5) By Alpha Blockers: Doxazosin, Prazosin, Terazosin

6) By Calcium Channel Blockers: Amlodipine, Diltiazem, Verapamil, Nifedipine

7) By Renin Inhibitors: Aliskiren

8) By Vasodilators: Hydralazine, Minoxidil

How Are Trends Influencing The Anti-Hypertensive Drugs Market?

Key companies operating within the anti-hypertensive drugs market are prioritizing the creation of novel products, such as Metoprolol Succinate Extended-Release Tablets, to secure a market advantage. Metoprolol Succinate Extended-Release Tablets are utilized as anti-hypertensive medications for individuals diagnosed with hypertension. For instance, in June 2023, Granules India Limited, an Indian-based pharmaceutical manufacturing corporation, introduced Metoprolol Succinate Extended-Release Tablets that received authorization from the Food and Drug Administration (FDA), a federal agency based in the US. Metoprolol Succinate Extended-Release Tablets function as anti-hypertensive drugs designed to manage hypertension by decreasing blood pressure. These tablets come in various dosages, including 25mg, 50mg, 100mg, and 200mg. The formulation includes beta-blockers that act to slow the heart rate, alleviate strain on the heart, and consequently reduce blood pressure.

Which Leading Companies Dominate The Anti-Hypertensive Drugs Market Share?

Major companies operating in the anti-hypertensive drugs market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbiVe Inc., Bayer AG, Novartis AG, Sanofi SA, Astra Zeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, C.H. Boehringer Sohn AG & Ko. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Fresenius Kabi AG, Sun Pharmaceuticals LLC, Cipla Limited, Dr. Reddy’s Laboratories, Hikma Pharmaceuticals PLC, Lupin Limited, Torrent Pharmaceuticals Ltd, Noden Pharma DAC, Actelion Pharmaceuticals Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Which Geographies Are Emerging As Strong Markets For The Anti-Hypertensive Drugs Industry?

North America was the largest region in the anti-hypertensive drugs market in 2024. The Middle East is expected to be the largest growing region in the global anti-hypertensive drugs market during the forecast period. The regions covered in the anti-hypertensive drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Anti-Hypertensive Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2410&type=smp

Browse Through More Reports Similar to the Global Anti-Hypertensive Drugs Market 2025, By The Business Research Company

Pharmaceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Hormonal Contraceptives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795